...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Recent ESC 2017 meeting and Steve Nissans comments

"Bear what is wrong with that. It's all about advising the public assuming that is what he is doing. No? Beside what's wrong with giving us a plug."

If you expect the ongoing apabetalone/BETonMACE cardiovascular outcomes trial, which isn't even fully enrolled or passed futility test, to be mentioned by Dr. Nissen in the context of the video highlighting 3 completed clinical trials, then you must also expect Dr. Nissen to discuss the various other ongoing, incomplete cardiovascular outcomes trials in addition to BETonMACE. That wouldn't exactly fit into a 6 minute video clip, eh?

It was a short video highlighting key results disclosed for the first time at ESC 2017 for the completed CANTOS, REVEAL and COMPASS studies. It wasn't a seminar on all ongoing, incomplete cardiovascular outcomes trials that may have some overlap with the mechanism/interests of the CANTOS, REVEAL and COMPASS studies.

BearDownAZ

 

Share
New Message
Please login to post a reply